← Evidence map

ReviewBlood advances2024

BTK inhibitors in CLL: second-generation drugs and beyond.

Constantine Tam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

60 papers cite it

2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38478390